Titan Pharmaceuticals Inc.
TTNP | NASDAQ
$2.34
$0.00 (0.00%)
Nov 2, 2026, 3:57 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 1K | 60K | 1.53M | 4.84M |
Cost of Revenue | n/a | 5K | n/a | 196K | 199K | 472K |
Gross Profit | n/a | -5K | 1K | -136K | 1.33M | 4.37M |
Operating Income | -2.42M | -4.56M | -7.28M | -10.24M | -9.35M | -7.35M |
Interest Income | n/a | 1K | 5K | 53K | 1K | n/a |
Pretax Income | -2.49M | -4.71M | -5.57M | -10.21M | -8.78M | -7.41M |
Net Income | -2.49M | -4.71M | -5.57M | -10.18M | -8.11M | -20.73M |
Selling & General & Admin | 2.42M | 4.56M | 5.55M | 6.03M | 4.99M | 5.8M |
Research & Development | n/a | n/a | 1.91M | 4.76M | 5.69M | 5.92M |
Other Expenses | n/a | n/a | -183K | -497K | -84K | n/a |
Operating Expenses | 2.42M | 4.56M | 7.28M | 10.3M | 10.68M | 11.72M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 769K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.42M | 4.56M | 7.46M | 10.3M | 10.88M | 12.19M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 846 | 899K | 752K | 671.7K | 2M | 2M |
Shares Outstanding (Diluted) | 846 | 899K | 752K | 671.7K | 2M | 2M |
EPS (Basic) | -2.94K | -5.23 | -7.41 | -15.15 | -4.06 | -10.38 |
EPS (Diluted) | -2.94K | -5.23 | -7.41 | -15.15 | -4.06 | -10.38 |
EBITDA | -2.42M | -4.7M | -7.17M | -10.04M | -9.13M | -7.06M |
EBIT | -2.42M | -4.71M | -7.28M | -10.24M | -9.35M | -7.35M |
Depreciation & Amortization | n/a | 5K | 112K | 196K | 221K | 292K |
Add to Watchlist
Select watchlists to add or remove TTNP